This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Eiken Kagaku Kabushiki Kaisha. Active years: 2022-2026.
Location History:
- Ohtawara, JP (2022)
- Tochigi, JP (2022)
Company Filing History:
Years Active: 2022-2026
Title: Satoru Michiyuki: Innovator in RNA Detection Technologies
Introduction
Satoru Michiyuki is a prominent inventor based in Otawara, Japan. He has made significant contributions to the field of molecular biology, particularly in the detection of RNA viruses and single nucleotide polymorphisms. With a total of 3 patents to his name, Michiyuki's work has the potential to impact various applications in medical diagnostics.
Latest Patents
Among his latest patents is a method for detecting single-stranded RNA viruses. This invention utilizes an oligonucleotide probe specifically designed for the detection of single nucleotide polymorphisms. The oligonucleotide probe comprises a reporter region, an anchor region, and a linker region. The reporter region includes an oligonucleotide that perfectly matches the first nucleotide of the single nucleotide polymorphism while mismatching other nucleotides. Additionally, it features a fluorescent dye that quenches when the reporter region hybridizes with the target nucleic acid.
Career Highlights
Satoru Michiyuki is associated with Eiken Kagaku Kabushiki Kaisha, a company known for its advancements in diagnostic technologies. His work at Eiken has allowed him to focus on innovative solutions that enhance the accuracy and efficiency of genetic testing.
Collaborations
Throughout his career, Michiyuki has collaborated with notable colleagues, including Hidetoshi Kanda and Kota Yokono. These collaborations have fostered a productive environment for research and development in the field of molecular diagnostics.
Conclusion
Satoru Michiyuki's contributions to RNA detection technologies exemplify the importance of innovation in medical diagnostics. His patents reflect a commitment to advancing scientific knowledge and improving healthcare outcomes.